» Articles » PMID: 17908721

Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2007 Oct 3
PMID 17908721
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ibuprofen is the most commonly used nonsteroidal, antipyretic, antiinflammatory analgesic in children. Nonsteroidal, antipyretic, antiinflammatory analgesics act in both the peripheral tissues and the central nervous system. The central nervous system penetration of ibuprofen has been described in adults but not in children.

Objectives: Our goals were to investigate the cerebrospinal fluid penetration of ibuprofen in children and evaluate the analgesic plasma concentration of ibuprofen after inguinal surgery in children.

Materials And Methods: A total 36 healthy children (25 boys) aged 3 months to 12 years received a single intravenous injection of ibuprofen (10 mg/kg). A paired cerebrospinal fluid and blood sample was obtained 10 minutes to 8 hours after the injection. In children having inguinal surgery, a second blood sample was obtained at the time that the child first had wound pain.

Results: The ibuprofen level was determined in all cerebrospinal fluid and plasma samples. Cerebrospinal fluid concentrations ranged between 15 and 541 microg/L, and the highest concentrations were measured 30 to 38 minutes after dosing. In all cerebrospinal fluid samples collected after 30 minutes, ibuprofen concentration exceeded that of unbound plasma. The plasma analgesic concentrations after inguinal surgery ranged between 10 and 25 mg/L.

Conclusions: Ibuprofen penetrates the cerebrospinal fluid readily, with peak concentrations attained 30 to 40 minutes after intravenous injection of a 10 mg/kg dose. The plasma analgesic concentration after inguinal surgery with spinal anesthesia is 10 to 25 mg/L.

Citing Articles

Updating Clinical Practice: Improving Perioperative Pain Management for Adeno-Tonsillectomy in Children.

Redondo-Enriquez J, Rivas-Medina M, Galan-Mateos M Children (Basel). 2024; 11(10).

PMID: 39457155 PMC: 11505956. DOI: 10.3390/children11101190.


What to Test in Parkinson Disease Prevention Trials? Repurposed, Low-Risk, and Gene-Targeted Drugs.

Crotty G, Schwarzschild M Neurology. 2022; 99(7 Suppl 1):34-41.

PMID: 35970592 PMC: 10519134. DOI: 10.1212/WNL.0000000000200238.


Preemptive analgesic effectiveness of single dose intravenous ibuprofen in infants undergoing cleft palate repair: a randomized controlled trial.

Peng Z, Wang Y, Zhang M, Zheng J, Hu J, Zhou W BMC Pediatr. 2021; 21(1):466.

PMID: 34674670 PMC: 8532298. DOI: 10.1186/s12887-021-02907-6.


Nonsteroidal Anti-Inflammatory Drugs and Their Neuroprotective Role After an Acute Spinal Cord Injury: A Systematic Review of Animal Models.

Lambrechts M, Cook J Global Spine J. 2020; 11(3):365-377.

PMID: 32875860 PMC: 8013945. DOI: 10.1177/2192568220901689.


Development of a physiologically-based pharmacokinetic pediatric brain model for prediction of cerebrospinal fluid drug concentrations and the influence of meningitis.

Verscheijden L, Koenderink J, de Wildt S, Russel F PLoS Comput Biol. 2019; 15(6):e1007117.

PMID: 31194730 PMC: 6592555. DOI: 10.1371/journal.pcbi.1007117.